No Detail Found!

Outcome of Intra-Lesional Bleomycin in the Management of Cystic Hygroma

Author(s)
GHULAM MUSTAFA Department of Pediatric Surgery, The Children’s Hospital and the Institute of Child Health, Lahore, Pakistan
BILAL MIRZA Department of Pediatric Surgery, The Children’s Hospital and the Institute of Child Health, Lahore, Pakistan
SARFRAZ AHMAD Department of Pediatric Surgery, The Children’s Hospital and the Institute of Child Health, Lahore, Pakistan
Nabila Talat Department of Pediatric Surgery, The Children’s Hospital and the Institute of Child Health, Lahore, Pakistan
Muhammad Saleem Department of Pediatric Surgery, The Children’s Hospital and the Institute of Child Health, Lahore, Pakistan
Afzal Sheikh Department of Pediatric Surgery, The Children’s Hospital and the Institute of Child Health, Lahore, Pakistan
Abstract
Background: Cystic hygroma or macrocystic lymphatic malformation commonly occurs at cervico-facial region and used to be treated with surgical excision. Now studies have documented superior results with sclerotherapy. Objective: To study the outcome of treatment with Intra-lesional bleomycin in the patients of cystic hygroma. Study design: A prospective case series. Setting: This study was conducted in the Pediatric Surgery Department, The Children’s Hospital & the Institute of Child Health Lahore. Material and Methods: Forty five patients of cystic hygroma in whom sclerotherapy was advised were enrolled. Inj bleomycin was injected intra-lesionally at a dose of 0.3mg/kg of body weight and number of sclerotherapy sessions ranged from 1 to 4 per patient. The sessions were repeated monthly and the size of the lesion was noted before each sclerotherapy session. The data was analyzed using SPSS version 20. Results: There were total 45 patients including 30 males and 15 females (M:F 1:0.5) having age range 1month to 12 years. Thirty patients (66.7%) showed complete resolution and 12 patients (26.7%) showed good response and 3 patients (6.7%) showed poor response and none of the patients showed no response. One patient showed complete resolution after 2 sessions of bleomycin; whereas, 12 patients showed complete resolution after three sessions of bleomycin, and 17 patients showed complete resolutions after 4 sessions of bleomycin. No serious/lethal side effects were observed. Conclusion: Bleomycin is effective and reliable for macro-cystic lymphatic malformations. There are no long term lethal side effects. It should be considered as primary therapy for cystic hygroma.
Publication Details
Page(s) 261-265
DOI DOI not available
Published Journal: Pakistan Paediatric Journal, Volume: 42, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Sclerotherapy, Bleomycin, Cystic hygroma, Lymphatic malformation
0

Citations

0

Downloads

85

Views